BriaCell Therapeutics Corp. - Common Shares (NQ:BCTX)

3.560 +0.060 (+1.71%)

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BriaCell Therapeutics Corp. - Common Shares

< Previous 1 2 3 4 Next >

BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily

May 30, 2023

CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment

Via TheNewswire.com

BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily

May 30, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

New Treatments May Help Those With Advanced Breast Cancer Live Longer

April 17, 2023

Via StatePoint Media

Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

March 24, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs...

Via FinancialNewsMedia

Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer ↗

February 08, 2023

A look at BriaCell's research into a better treatment for prostate cancer.

Via Talk Markets

BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers ↗

January 18, 2023

From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock...

Via Talk Markets

BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer ↗

January 18, 2023

Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach.

Via Talk Markets

BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients

December 14, 2022

By Ernest Dela Aglanu, Benzinga

Via News Direct

Topics Death

BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients

December 14, 2022

Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing...

Via TheNewswire.com

Topics Death

BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients ↗

December 13, 2022

Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX<

Via Benzinga

BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients

December 02, 2022

The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs...

Via TheNewswire.com

Topics Stocks

BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients

December 02, 2022

By Faith Ashmore, Benzinga

Via News Direct

BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients ↗

December 01, 2022

The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption.

Via Benzinga

IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies

November 30, 2022

From ImmunoPrecise Antibodies

Via Business Wire

Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday ↗

September 20, 2022

Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.

Via Benzinga

Why Is BriaCell (BCTX) Stock Moving Today? ↗

April 13, 2022

BriaCell Therapeutics (BCTX) stock is on the move Wednesday morning after getting Fast Track approval from the FDA for Bria-IMT.

Via InvestorPlace

Benzinga's Daily Brief On Trending Tickers For April 13, 2022: JPMorgan, PayPal, Bed Bath & Beyond And More ↗

April 13, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...

Via Benzinga

Why BriaCell Therapeutics Stock Is Surging Today ↗

April 13, 2022

BriaCell Therapeutics Corp (NASDAQ: BCTX) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Fast Track status...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022 ↗

February 14, 2022

Upgrades According to Mizuho, the prior rating for Murphy Oil Corp (NYSE:MUR) was changed from Neutral to Buy. In the fourth quarter, Murphy Oil showed an EPS of $0.40,...

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 25, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...

Via Benzinga

Drug Combinations and New Approvals Delivering Optimistic Results in Oncology Stocks

December 08, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –December 8, 2021 – USA News Group – Growing at a healthy CAGR of 14.1%, the Cancer Immunotherapy Market is being projected to hit...

Via FinancialNewsMedia

54 Stocks Moving In Monday's Mid-Day Session ↗

January 24, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of...

Via Benzinga

Short Squeeze Stocks: PROG, SAVA and 3 Others Experts Think Are Ready to Pop ↗

November 08, 2021

Fintel's list of short squeeze stocks to watch for this week is in. Here are the names that investors should be watching.

Via InvestorPlace

Big Trend Occurring in Triple-Negative Breast Cancer Treatment Is The Shift Towards Combination Therapy

December 10, 2021

Palm Beach, FL – December 10, 2021 – FinancialNewsMedia.com News Commentary – Ongoing advancements in cancer research continue to lead to the introduction of newer and better treatment options...

Via FinancialNewsMedia

5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Cassava Sciences Joins Following Short Report ↗

November 08, 2021

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE:

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 01, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...

Via Benzinga

Topics Intellectual Property

45 Biggest Movers From Yesterday ↗

October 13, 2021

Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

BriaCell's Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer ↗

September 23, 2021

Photo by Artem Podrez from Pexels Too many companies and small businesses to count were buried under the avalanche of a global pandemic in the past 18 months. And as horrible as...

Via Benzinga

BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial ↗

August 19, 2021

BriaCell Therapeutics Corp (NASDAQ: BCTX) has announced a multi-year, non-exclusive license agreement with ImaginAb Inc for developing next-generation...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.